Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MetPAP: Methionine for MARS-mutated Pulmonary Alveolar Proteinosis
NCT03887169Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2019
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methionine in pulmonary alveolar proteinosis (PAP), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Tolerance Assessment. Started Sep 2019; status: completed.
02
Drugs
methionine
03
Conditions
pulmonary alveolar proteinosis (PAP)
Beyond the preview
Go deeper on NCT03887169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03887169.